| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.07 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.096 | 0.07 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.07 |